VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis
about
Emerging role of microRNAs in lipid metabolismVEGF-A Stimulates STAT3 Activity via Nitrosylation of Myocardin to Regulate the Expression of Vascular Smooth Muscle Cell Differentiation Markers.Vascular endothelial growth factor antagonist therapy for retinopathy of prematuritySafety and angiogenic effects of systemic gene delivery of a modified erythropoietin.KLF4 Promotes Angiogenesis by Activating VEGF Signaling in Human Retinal Microvascular Endothelial Cells.Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathyTwist promotes angiogenesis in pancreatic cancer by targeting miR-497/VEGFA axis.Protective effect of maternal uteroplacental insufficiency on oxygen-induced retinopathy in offspring: removing bias of premature birthAssociation between macular degeneration and mild to moderate chronic kidney disease: A nationwide population-based study.Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy.Pathophysiology and mechanisms of severe retinopathy of prematurity.SIRT1 mediated inhibition of VEGF/VEGFR2 signaling by Resveratrol and its relevance to choroidal neovascularization.Revisiting the role of erythropoietin for treatment of ocular disorders.Advances in understanding and management of retinopathy of prematurity.Erythropoietin and Its Angiogenic Activity.Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization.Effects of Erythropoietin Receptor Activity on Angiogenesis, Tubular Injury and Fibrosis in Acute Kidney Injury: A "U-Shaped" Relationship.Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt signaling pathway.The genetics of retinopathy of prematurity: a model for neovascular retinal disease
P2860
Q26852591-A06F3BC5-7C10-4107-981A-E37F50A3FDEEQ33752963-6A351B1E-A590-4DBA-8FA0-2D2A8B86E140Q35473907-8B6EEFE9-C808-4A67-8E45-0FEA38E14706Q35587285-115AAC75-5D5F-41DC-B733-1B7F494A22ADQ35663864-7BCB01DC-689A-4D3F-8A8B-814196297799Q35741127-5F0D36D0-8AF2-4219-A7EF-7D8CC645B30AQ36379513-B8C5AF35-64BB-4AFB-9D40-7D41605F7B6EQ37295501-E8564AE2-7DEF-4B19-841F-D08051164AC4Q37640165-7D8F3104-CD3D-4A42-91DF-386A96DDDEEFQ37725392-D867950F-03D9-4AB2-9DBB-E1AE3EA194B4Q37744827-5BD6CF01-2BC5-4938-B976-EF496443D611Q38274655-D3699F6D-805E-47B9-9466-914A4C3671B2Q38853023-2482AC5B-531E-4AFF-99A0-3B2E05F9A984Q38855251-D3DB21BB-81D4-4FD1-A692-4B580838EB9EQ39052915-ABCB55FA-77D3-4B2D-81C0-BAA0AFE423C2Q39432541-62C9C18D-77CE-4B3A-820D-FEAF7027AC04Q48120672-E381D8B4-DA18-488E-942D-4B66C43E8EDEQ49541601-F3659980-6A74-499F-B7A4-5A0401BDFDBEQ52714865-A6D6DE50-B199-45A4-93D9-D9AA853A0B71Q57165717-93651DEA-29AA-4142-B78D-ABCF749ED4B9
P2860
VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
VEGFA activates erythropoietin ...... ated pathological angiogenesis
@en
type
label
VEGFA activates erythropoietin ...... ated pathological angiogenesis
@en
prefLabel
VEGFA activates erythropoietin ...... ated pathological angiogenesis
@en
P2093
P2860
P1476
VEGFA activates erythropoietin ...... ated pathological angiogenesis
@en
P2093
Haibo Wang
M Elizabeth Hartnett
Yanchao Jiang
Zhihong Yang
P2860
P304
P356
10.1016/J.AJPATH.2013.12.023
P407
P577
2014-03-12T00:00:00Z